Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 1/2012

01-03-2012 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Surgical Approach to Mitral Regurgitation in Chronic Heart Failure: When Is It an Option?

Author: Juan A. Crestanello

Published in: Current Heart Failure Reports | Issue 1/2012

Login to get access

Abstract

Functional mitral regurgitation (MR) is common in patients with chronic heart failure and adversely affects survival and quality of life. Surgery is effective in improving symptoms and reverse remodeling of the ventricle. However, its effect on survival is unclear. Indications for surgery are challenging given the elevated surgical risk of these patients, lack of prospective randomized data, and uncertain long-term results in the historical series. A systematic approach to functional mitral regurgitation that addresses both the mitral insufficiency and the ventricular remodeling with careful patient selection can achieve reliable, reproducible, and lasting results. This article reviews the surgical procedures to treat functional mitral regurgitation and presents an algorithm for their application in patients with congestive heart failure.
Literature
1.
Robbins JD, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003;91(3):360–2.PubMedCrossRef
2.
Patel JB, Borgeson DD, Barnes ME, et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail. 2004;10(4):285–91.PubMedCrossRef
3.
Borger MA, Alam A, Murphy PM, et al. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg. 2006;81(3):1153–61. Review.PubMedCrossRef
4.
•• Lancellotti P, Marwick T, Pierard LA: How to manage ischaemic mitral regurgitation. Heart. 2008;94(11):1497–502. This is an excellent review on the management of ischemic MR. PubMedCrossRef
5.
Bolling SF, Smolens IA, Pagani FD. Surgical alternatives for heart failure. J Heart Lung Transplant. 200;20(7):729–33. Review.CrossRef
6.
• Magne J, Sénéchal M, Dumesnil JG, Pibarot P: Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology. 2009;112(4):244–59. Epub 2008 Aug 30. Review. This article reviews pathophysiology, treatment, and outcomes of ischemic MR. PubMedCrossRef
7.
Levine RA, Hung J, Otsuji Y, et al. Mechanistic insights into functional mitral regurgitation. Curr Cardiol Rep. 2002;4(2):125–9.PubMedCrossRef
8.
Bursi F, Enriquez-Sarano M, Jacobsen SJ, Roger VL. Mitral regurgitation after myocardial infarction: a review. Am J Med. 2006;119(2):103–12. review.PubMedCrossRef
9.
Romano MA, Bolling SF. Update on mitral repair in dilated cardiomyopathy. J Card Surg. 2004;19(5):396–400.PubMedCrossRef
10.
Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation. 2006;114(1 Suppl):I67–71.PubMed
11.
Carabello BA. The management of functional mitral regurgitation. Curr Cardiol Rep. 2007;9(2):112–7. Review.PubMedCrossRef
12.
Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol. 2008;52(5):319–26. Review.PubMedCrossRef
13.
Bouma W, van der Horst IC, Wijdh-den Hamer IJ, et al. Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. Eur J Cardiothorac Surg. 2010;37(1):170–85. Epub 2009 Aug 27. PubMed PMID: 19716310.PubMedCrossRef
14.
Jones RH, Velazquez EJ, Michler RE, et al. STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360(17):1705–17.PubMedCrossRef
15.
Grigioni F, Detaint D, Avierinos JF, et al. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol. 2005;45(2):260–7.PubMedCrossRef
16.
Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759–64.PubMed
17.
Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111(3):295–301. Epub 2005 Jan 17.PubMedCrossRef
18.
Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation. 1997;96:827–33.PubMed
19.
• Agricola E, Stella S, Figini F, et al.: Non-ischemic dilated cardiopathy: prognostic value of functional mitral regurgitation. Int J Cardiol. 2011; 146(3):426–8. Epub 2010 Nov 20. PubMed PMID: 21094544. This study shows that as MR severity worsens, long-term survival also worsened. PubMedCrossRef
20.
Trichon BH, O’Connor CM. Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated? Am Heart J. 2002;144(3):373–6. Review.PubMedCrossRef
21.
Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538–43.PubMedCrossRef
22.
• Agricola E, Oppizzi M, Pisani M, et al.: Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9(2):207–21. This review describes patterns of ventricular remodeling, annular dilatation, and mitral regurgitation. PubMed
23.
Watanabe N, Ogasawara Y, Yamaura Y, et al. Geometric differences of the mitral valve tenting between anterior and inferior myocardial infarction with significant ischemic mitral regurgitation: quantitation by novel software system with transthoracic real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2006;19(1):71–5.PubMedCrossRef
24.
Nagasaki M, Nishimura S, Ohtaki E, et al. The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy. Int J Cardiol. 2006;108(2):171–6.PubMedCrossRef
25.
Kwan J, Shiota T, Agler DA, et al. Real-time three-dimensional echocardiography study. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation. 2003;107(8):1135–40.PubMedCrossRef
26.
Geidel S, Lass M, Krause K, et al. Early and late results of restrictive mitral valve annuloplasty in 121 patients with cardiomyopathy and chronic mitral regurgitation. Thorac Cardiovasc Surg. 2008;56(5):262–8.PubMedCrossRef
27.
Gummert JF, Rahmel A, Bucerius J, et al. Mitral valve repair in patients with end stage cardiomyopathy: who benefits? Eur J Cardiothorac Surg. 2003;23(6):1017–22. discussion 1022.PubMedCrossRef
28.
Hueb AC, Jatene FB, Moreira LF, et al. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg. 2002;124(6):1216–24.PubMedCrossRef
29.
Lorusso R, De Bonis M, De Cicco G, et al. Mitral insufficiency and its different aetiologies: old and new insights for appropriate surgical indications and treatment. J Cardiovasc Med (Hagerstown). 2007;8(2):108–13. Review.CrossRef
30.
Miura T, Eishi K, Yamachika S, et al. Isolated undersized mitral annuloplasty for functional mitral regurgitation in non-ischemic dilated cardiomyopathy: reconsideration of the relationship between preoperative coaptation depth and persistent mitral regurgitation. Circ J. 2008;72(11):1744–50. Epub 2008 Sep 18.PubMedCrossRef
31.
Spoor MT, Bolling SF. Valve pathology in heart failure: which valves can be fixed? Heart Fail Clin. 2007;3(3):289–98. Review.PubMedCrossRef
32.
Daimon M, Fukuda S, Adams DH, et al. Mitral valve repair with Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring for ischemic mitral regurgitation: early echocardiographic results from a multi-center study. Circulation. 2006;114(1 Suppl):I588–93.PubMed
33.
Mosquera VX, Bouzas-Mosquera A, Estévez F, et al. Mitral valve repair for ischemic mitral regurgitation using the Carpentier-McCarthy-Adams IMR ETlogix® ring: medium-term echocardiographic findings. Rev Esp Cardiol. 2010;63(10):1200–4. English, Spanish. PubMed PMID:20875361.PubMedCrossRef
34.
Votta E, Maisano F, Bolling SF, et al. The Geoform disease-specific annuloplasty system: a finite element study. Ann Thorac Surg. 2007;84(1):92–101.PubMedCrossRef
35.
Mahmood F, Gorman 3rd JH, Subramaniam B, et al. Changes in mitral valve annular geometry after repair: saddle-shaped versus flat annuloplasty rings. Ann Thorac Surg. 2010;90(4):1212–20. PubMed PMID: 20868816; PubMed Central PMCID: PMC3021250.PubMedCrossRef
36.
McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128(6):916–24.PubMedCrossRef
37.
Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110(11 Suppl 1):II103–8.PubMed
38.
Kim YH, Czer LS, Soukiasian HJ, et al. Ischemic mitral regurgitation: revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg. 2005;79(6):1895–901.PubMedCrossRef
39.
•• Braun J, van de Veire NR, Klautz RJ, et al.: Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85(2):430–6. This article identifies a LVEDD less than 65 mm as predictor of reverse remodeling, repair durability, and improved survival.PubMedCrossRef
40.
Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49(22):2191–201. Epub 2007 May 18.PubMedCrossRef
41.
• Acker MA, Jessup M, Bolling SF, et al.: Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. J Thorac Cardiovasc Surg. 2011 Jan 24. [Epub ahead of print] PubMed PMID: 21269649. This study demonstrated a positive cumulative effect of adding a ventricular restrain procedure to mitral annuloplasty.
42.
Onorati F, Rubino AS, Marturano D, et al. Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2009;138:654–62.PubMedCrossRef
43.
De Bonis M, Lapenna E, Verzini A, et al. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann Thorac Surg. 2008;85(3):932–9.PubMedCrossRef
44.
Gelsomino S, Lorusso R, Caciolli S, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136(2):507–18. Epub 2008 May 2.PubMedCrossRef
45.
Kuwahara E, Otsuji Y, Iguro Y, et al. Mechanism of recurrent/persistent ischemic/functional mitral regurgitation in the chronic phase after surgical annuloplasty: importance of augmented posterior leaflet tethering. Circulation. 2006;114(1 Suppl):I529–34.PubMed
46.
Gelsomino S, Lorusso R, Capecchi I, et al. Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann Thorac Surg. 2008;85(4):1319–30.PubMedCrossRef
47.
Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg. 2001;122(6):1107–24.PubMedCrossRef
48.
Gelsomino S, Lorusso R, De Cicco G, et al. Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation. Eur Heart J. 2008;29(2):231–40. Epub 2007 Nov 7.PubMedCrossRef
49.
• Calafiore AM, Iacò AL, Bivona A, et al.: Echocardiographically based treatment of chronic ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2011; 141(5):1150–6.e1. Epub 2010 Aug 14. PubMed PMID: 20709335. The authors describe a tailored approach to ischemic mitral regurgitation based on echocardiographic findings that predicts recurrence. PubMedCrossRef
50.
Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg. 2004;77:1989–97.PubMedCrossRef
51.
Miller DC. Ischemic mitral regurgitation redux–to repair or to replace? J Thorac Cardiovasc Surg. 2001;122(6):1059–62.PubMedCrossRef
52.
Ciarka A, Braun J, Delgado V, et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol. 2010;106(3):395–401.PubMedCrossRef
53.
Kongsaerepong V, Shiota M, Gillinov AM, et al. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol. 2006;98(4):504–8. Epub 2006 Jun 21. PubMedPMID: 16893706.PubMedCrossRef
54.
Yamauchi T, Taniguchi K, Kuki S, et al. Evaluation of the mitral valve leaflet morphology after mitral valve reconstruction with a concept “coaptation length index”. J Card Surg. 2005;20:432–5.PubMedCrossRef
55.
Anyanwu AC, Adams DH. Ischemic mitral regurgitation: recent advances. Curr Treat Options Cardiovasc Med. 2008;10(6):529–37.PubMedCrossRef
56.
•• Anyanwu AC, Adams DH: Why do mitral valve repairs fail? J Am Soc Echocardiogr. 2009; 22(11):1265–8. PubMed PMID: 19883875. This is an excellent review that examines the causes for recurrent mitral regurgitation. PubMedCrossRef
57.
Silberman S, Klutstein MW, Sabag T, et al. Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann Thorac Surg. 2009;87:1721–6.PubMedCrossRef
58.
Zhu F, Otsuji Y, Yotsumoto G, et al. Mechanism of persistent ischemic mitral regurgitation after annuloplasty: importance of augmented posterior mitral leaflet tethering. Circulation. 2005;112:I396–401.PubMedCrossRef
59.
Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation. 2004;110:II85–90.PubMedCrossRef
60.
Magne J, Pibarot P, Dumesnil JG, Sénéchal M. Continued global left ventricular remodeling is not the sole mechanism responsible for the late recurrence of ischemic mitral regurgitation after restrictive annuloplasty. J Am Soc Echocardiogr. 2009;22(11):1256–64. Epub 2009 Oct 7.PubMedCrossRef
61.
Tahta SA, Oury JH, Maxwell JM, et al. Outcome after mitral valve repair for ischemic mitral regurgitation. J Heart Valve Dis. 2002;11:11.PubMed
62.
Crabtree TD, Bailey MS, Moon MR, et al. Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg. 2008;85(5):1537–42. discussion 1542–3.PubMedCrossRef
63.
Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45(3):381–7.PubMedCrossRef
64.
Tolis Jr GA, Korkolis DP, Kopf GS, Elefteriades JA. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg. 2002;74(5):1476–80. discussion 1480–1.PubMedCrossRef
65.
•• Fattouch K, Guccione F, Sampognaro R, et al.: POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009; 138(2):278–85. Epub 2009 May 31. PubMed PMID: 19619766. This randomized prospective trial shows that mitral annuloplasty and CABG for cured moderate MR, reversed remodeling, but did not change survival. PubMedCrossRef
66.
Fattouch K, Sampognaro R, Speziale G, et al. Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg. 2010;90(4):1187–94.PubMedCrossRef
67.
Maisano F, Caldarola A, Blasio A, et al. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg. 2003;126:1987–97.PubMedCrossRef
68.
De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the “edge-to-edge” technique. Circulation. 2005;112(9 Suppl):I402–8.PubMed
69.
Magne J, Girerd N, Sénéchal M, et al. Mitral repair versus replacement for ischemic mitral regurgitation: comparison of short-term and long-term survival. Circulation. 2009;120(11 Suppl):S104–11.PubMedCrossRef
70.
David TE. Papillary muscle-annular continuity: is it important? J Card Surg. 1994;9(2 Suppl):252–4. Review. PubMed PMID: 8186577.PubMedCrossRef
71.
Sarris GE, Miller DC. Valvular-ventricular interaction: the importance of the mitral chordae tendineae in terms of global left ventricular systolic function. J Card Surg. 1988;3(3):215–34. Review. PubMed PMID: 2980020.PubMedCrossRef
72.
Murphy MO, Rao C, Punjabi PP, Athanasiou T. In patients undergoing mitral surgery for ischaemic mitral regurgitation is it preferable to repair or replace the mitral valve? Interact Cardiovasc Thorac Surg. 2011;12(2):218–27. Epub 2010 Nov 18. Review. PubMed PMID: 21088201.PubMedCrossRef
73.
• Vassileva CM, Boley T, Markwell S, Hazelrigg S: Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2011; 39(3):295–303. Epub 2010 Aug 19. PubMed PMID: 20727782. This meta-analysis demonstrates worse early and late outcomes with mitral valve replacement. PubMedCrossRef
74.
Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122(6):1125–41.PubMedCrossRef
75.
Qiu Z, Chen X, Xu M, et al. Is mitral valve repair superior to replacement for chronic ischemic mitral regurgitation with left ventricular dysfunction? J Cardiothorac Surg. 2010;5:107. PubMed PMID: 21059216; PubMed Central PMCID: PMC2987923.PubMedCrossRef
76.
77.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.PubMedCrossRef
78.
Elefteriades JA, Tolis Jr G, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411–7.PubMedCrossRef
79.
Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52(13):e1–e142. PubMed PMID: 18848134.PubMedCrossRef
80.
Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation. 2004;110(11 Suppl 1):II18–22.PubMed
81.
Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability. Cardiol Clin. 2007;25(1):35–56. v. Review. PubMed PMID: 17478239.PubMedCrossRef
82.
Menicanti L, Di Donato M, Frigoiola A, et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J Thorac Cardiovasc Surg. 2002;123:1041–50.PubMedCrossRef
83.
Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg. 2002;74:600–1.PubMedCrossRef
84.
Menicanti L, DiDonato M, Castelvecchio S, et al. Functional ischemic mitral regurgitation in anterior ventricular remodeling: results of surgical ventricular restoration with and without mitral repair. Heart Fail Rev. 2004;9(4):317–27.PubMedCrossRef
85.
Prucz RB, Weiss ES, Patel ND, et al. The impact of surgical ventricular restoration on mitral valve regurgitation. Ann Thorac Surg. 2008;86(3):726–34. discussion 726–34.PubMedCrossRef
86.
Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2007;133(6):1483–92. Epub 2007 Apr27. PubMed PMID: 17532944.PubMedCrossRef
87.
Hung J, Guerrero JL, Handschumacher MD, et al. Reverse ventricular remodeling reduces ischemic mitral regurgitation: echo-guided device application in the beating heart. Circulation. 2002;106(20):2594–600.PubMedCrossRef
88.
Solis J, Levine RA, Johnson B, et al. Polymer injection therapy to reverse remodel the papillary muscles: efficacy in reducing mitral regurgitation in a chronic ischemic model. Circ Cardiovasc Interv. 2010;3(5):499–505. Epub 2010 Aug 24. PubMed PMID: 20736444; PubMed Central PMCID: PMC2972670.PubMedCrossRef
89.
Grossi EA, Patel N, Woo YJ, et al. RESTOR-MV Study Group. Outcomes of the RESTOR-MV Trial (Randomized Evaluation of a Surgical Treatment for Off-Pump Repair of the Mitral Valve). J Am Coll Cardiol. 2010;56(24):1984–93. PubMed PMID: 21126639.PubMedCrossRef
90.
Krishnaswamy A, Marc Gillinov A, Griffin BP. Ischemic mitral regurgitation: pathophysiology, diagnosis, and treatment. Coron Artery Dis. 2011;22(5):359–70. PubMed PMID: 21572322.PubMedCrossRef
91.
Feldman T, Foster E, Glower DD, et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–406. Epub 2011 Apr 4.PubMedCrossRef
92.
Alfieri O, Denti P. Alfieri stitch and its impact on mitral clip. Eur J Cardiothorac Surg. 2011;39(6):807–8. Epub 2011 Feb 25. PubMed PMID: 21353584.PubMedCrossRef
93.
Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68. Epub 2007 Jan 26. PubMed PMID: 17259184.PubMedCrossRef
94.
Yamano T, Gillinov AM, Takasaki K, et al. Is revascularization alone truly sufficient in patients with mild mitral regurgitation?: Echocardiographic follow-up of mild ischemic mitral regurgitation after isolated coronary artery bypass grafting. Circulation. 2008;118(18):S699–9. Supplement: Suppl. 2.
95.
Lam BK, Gillinov AM, Blackstone EH, et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg. 2005;79(2)):462–70. discussion 462–70.PubMedCrossRef
96.
Calafiore AM, Mazzei V, Iacò AL, et al. Impact of ischemic mitral regurgitation on long-term outcome of patients with ejection fraction above 0.30 undergoing first isolated myocardial revascularization. Ann Thorac Surg. 2008;86(2):458–64. discussion 464–5.PubMedCrossRef
97.
•• Penicka M, Linkova H, Lang O, et al.: Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120(15):1474–81. The authors suggest that moderate MR may be cured in selected patients with isolated CABG. PubMedCrossRef
98.
99.
Digiammarco G, Liberi R, Giancane M, et al. Recurrence of functional mitral regurgitation in patients with dilated cardiomyopathy undergoing mitral valve repair: how to predict it. Interact Cardiovasc Thorac Surg. 2007;6(3):340–4. Epub 2007 Mar 26.PubMedCrossRef
100.
Calafiore AM, Gallina S, Di Mauro M, et al. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg. 2001;71(4):1146–52. discussion 1152–3.PubMedCrossRef
Metadata
Title
Surgical Approach to Mitral Regurgitation in Chronic Heart Failure: When Is It an Option?
Author
Juan A. Crestanello
Publication date
01-03-2012
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 1/2012
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-011-0080-6

Other articles of this Issue 1/2012

Current Heart Failure Reports 1/2012 Go to the issue

Pharmacologic Therapy (W. H. Wilson Tang, Section Editor)

Pharmacologic Strategies to Target Oxidative Stress in Heart Failure

Pharmacologic Therapy (W. H. Wilson Tang, Section editor)

Medical Therapy for Acute Decompensated Heart Failure: What Recent Clinical Trials Have Taught Us About Diuretics and Vasodilators

Pharmacologic Therapy (W. H. Wilson Tang, Section Editor)

Pharmacogenetics in Chronic Heart Failure: New Developments and Current Challenges

Pharmacologic Therapy (WHW Tang, Section Editor)

Should We Start Prescribing Omega-3 Polyunsaturated Fatty Acids in Chronic Heart Failure?

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Clinical Use of Telemonitoring in Chronic Heart Failure: Keeping up with the Times or Misuse of Time?

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits